2014
Re: Nader Al Nakouzi, Sylvestre le Moulec, Laurence Albigès, et al. Cabazitaxel Remains Active in Patients Progressing after Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies. Eur Urol. in press. http://dx.doi.org/10.1016/j.eururo.2014.04.015
Publication
Publication
European Urology : Official Journal of the European Association of Urology , Volume 66 - Issue 4
Additional Metadata | |
---|---|
doi.org/10.1016/j.eururo.2014.06.038, hdl.handle.net/1765/83512 | |
European Urology : Official Journal of the European Association of Urology | |
Organisation | Department of Urology |
van Soest, R. J., De Wit, R., & van Weerden, W. (2014). Re: Nader Al Nakouzi, Sylvestre le Moulec, Laurence Albigès, et al. Cabazitaxel Remains Active in Patients Progressing after Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies. Eur Urol. in press. http://dx.doi.org/10.1016/j.eururo.2014.04.015. European Urology : Official Journal of the European Association of Urology, 66(4). doi:10.1016/j.eururo.2014.06.038 |